Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On January 25, 2023, the Board of Directors (the "Board") of Baker Hughes
Company (the "Company") elected Dr. Mohsen M. Sohi to serve as a director of the
Company, effective January 25, 2023, following the resignation of Gregory L.
Ebel as previously disclosed in our Current Report on Form 8-K, filed with the
Securities and Exchange Commission on October 7, 2022.
Dr. Sohi is the Chief Executive Officer ("CEO") of Freudenberg SE
("Freudenberg"), a general multi-industry company serving industries that
include automotive, medical, aerospace, oil and gas, and power generation and
transmission, since July 2012. Dr. Sohi also serves as a director and the
chairman of the board of directors of STERIS plc, a provider of infection
prevention, decontamination, and health science technologies, products, and
services, since July 2005 and July 2018, respectively.
The Board has determined that Dr. Sohi is independent under the corporate
governance requirements of Nasdaq and the independence requirements of Rule
10A-3 of the Securities Exchange Act of 1934, as amended. Dr. Sohi will serve on
the Human Capital and Compensation Committee of the Board.
Dr. Sohi's compensation will be consistent with that of other non-employee
directors.
There are no arrangements or understandings between Dr. Sohi and any other
person pursuant to which Dr. Sohi was selected as a director and there are no
related party transactions between the Company and Dr. Sohi that would require
disclosure under Item 404(a) of Regulation S-K. From time to time, the Company
has entered into, and expects to enter into, ordinary course and arms-length
purchase and sale contracts with Freudenberg. Any such future transactions are
subject to the procedures of the Company's related party transactions policy. In
connection with his appointment, Dr. Sohi will enter into a standard
indemnification agreement with the Company in the form previously approved by
the Board.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
On January 25, 2023, the Board adopted the fifth amended and restated bylaws of
the Company (the "Fifth Amended and Restated Bylaws"), effective January 25,
2023, to update for changes in the Delaware General Corporate Law (the "DGCL")
and implement edits related to the new Rule 14a-19 under the Securities Act of
1934, as amended ("Rule 14a-19").
Section 1.5 of the Fifth Amended and Restated Bylaws has been revised to reflect
the updated Section 219(a) of the DGCL, which no longer requires the Company to
make the stockholder list available for inspection during the stockholders'
meeting.
Sections 1.10 and 1.12 of the Fifth Amended and Restated Bylaws have been
amended to address matters relating to Rule 14a-19 including (i) a requirement
that detailed information be provided for parties from whom the proponent is
receiving funding related to the proposal, (ii) a requirement if a proponent
fails to comply with requirements of Rule 14a-19 or, if requested by the
Company, fails to deliver reasonable evidence of the satisfaction of
requirements of Rule 14a-19 at least five business days before the applicable
meeting, then the nomination of any proposed nominee by such proponent shall be
disregarded, and (iii) agree in writing as part of the Nomination Notice (as
defined therein) to comply with requirements of Rule 14a-19, among other minor
edits by the Company.
The Fifth Amended and Restated Bylaws also include conforming changes.
The foregoing description of the amendments made in the Fifth Amended and
Restated Bylaws does not purport to be complete and is qualified by reference to
the Fifth Amended and Restated Bylaws, a copy of which is attached hereto as
Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
Item 9.01 Financial Statements and Exhibits. (Information furnished in this Item
9.01 is furnished pursuant to Item 9.01.)
(d) Exhibits.
3.1 Fifth Amended and Restated Bylaws of Baker Hughes Company dated
January 25, 2023
104* Cover Page Interactive Data File (formatted as Inline XBRL and contained
in Exhibit 101)
* Furnished herewith.
© Edgar Online, source Glimpses